Finasteride Cost in Florida 2026: Cash Pay, Insurance, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in Florida Right Now?

Generic finasteride is one of the most affordable prescription drugs in Florida. At major retail chains and independent pharmacies across the state, a 30-day supply of 1 mg finasteride runs approximately $12 cash-pay in 2026. Brand Propecia carries a list price closer to $85 per month, though very few patients pay that figure after discount programs are applied.

The price gap between brand and generic exists because Merck's patent on finasteride expired years ago, opening the market to multiple manufacturers. The FDA maintains a list of therapeutically equivalent generic finasteride products, all rated "AB" for substitution [1]. That equivalence rating means a pharmacist can legally substitute without a brand-specific prescription in Florida.

Prices vary by pharmacy. A GoodRx coupon applied at a Publix, CVS, or Walmart in Miami, Orlando, or Jacksonville can push the 30-tablet cost below $10. Costco's pharmacy, open to non-members in Florida for prescription purchases, often lists finasteride 1 mg near $7 to $9 for 30 tablets. These figures fluctuate with wholesaler contracts, so confirm pricing at the point of purchase.

For the 5 mg formulation used in benign prostatic hyperplasia (BPH), the cash-pay price is similarly low, typically $10 to $15 for 30 tablets at generics-focused pharmacies. Some providers prescribe 5 mg tablets for patients who split them into quarters as a cost-saving strategy for AGA, though this requires physician guidance given tablet coating and dose accuracy considerations [2].

The Endocrine Society's 2022 guidelines on androgenetic alopecia note that finasteride 1 mg daily is supported by Level I evidence and is considered a first-line pharmacologic option for male pattern hair loss [3]. That guideline status reinforces why access at an affordable price point matters clinically.

Florida Medicaid and Finasteride: What the Formulary Says

Florida Medicaid does not cover finasteride for androgenetic alopecia (AGA) or benign prostatic hyperplasia (BPH) on its standard preferred drug list. The drug is excluded from the Florida Medicaid formulary for these indications. Patients relying on Florida Medicaid for hair-loss treatment will need to pay out of pocket or pursue manufacturer assistance programs.

Florida Medicaid is administered through managed care organizations under the Statewide Medicaid Managed Care (SMMC) program [4]. Each plan maintains its own formulary, but none of the major contracted plans include finasteride for cosmetic or hair-loss indications as of 2026. BPH coverage is similarly absent from most managed care plan tiers under SMMC.

Patients who believe they have a medical necessity argument, such as finasteride use as part of gender-affirming hormone therapy, should work with their prescribing clinician to submit a prior authorization request. The Florida Agency for Health Care Administration (AHCA) oversees the prior authorization process and outlines appeal rights [5]. Success rates for PA appeals vary, and the clinical documentation burden is significant.

Dual-eligible patients who carry Medicare Part D alongside Medicaid may find better coverage. Several Part D plans include generic finasteride for BPH (not AGA) on their formularies at Tier 1 or Tier 2 copays. The Medicare Plan Finder tool at CMS.gov allows Florida residents to filter by drug before enrollment [6].

Is Compounded Finasteride Legal in Florida?

Yes. Licensed 503A compounding pharmacies in Florida may legally compound finasteride for individual patients under a valid prescription. The Florida Board of Pharmacy regulates 503A compounders, and compounded finasteride is not currently on the FDA's list of drugs withdrawn from the market for safety reasons, which means it remains eligible for compounding under federal law [7].

The cost advantage is real but partial. Compounded finasteride from a licensed Florida 503A pharmacy typically runs $40 to $50 per month. That is three to four times the cash-pay price for standard generic tablets. The premium reflects customization options: some patients are prescribed topical finasteride solutions or finasteride combined with minoxidil in a single formulation, neither of which is available as an FDA-approved finished product [8].

Topical finasteride has attracted research interest because of its potential to lower systemic dihydrotestosterone (DHT) exposure compared with oral dosing. A 2021 study in the Journal of the American Academy of Dermatology (N=323) found that topical finasteride 0.25% once daily reduced scalp DHT by 46.9% and produced hair count outcomes statistically non-inferior to oral 1 mg finasteride at 24 weeks [9]. Systemic DHT suppression was 27.4% with the topical vs. 66.3% with oral, a finding relevant to patients concerned about systemic side effects.

Florida's Board of Pharmacy enforces strict oversight of compounding practices under Chapter 465, Florida Statutes [10]. Patients should verify that any pharmacy compounding finasteride holds an active Florida permit and complies with USP Chapter 795 standards for non-sterile preparations. The Florida Department of Health license verification tool allows public lookup of pharmacy permits online [11].

503B outsourcing facilities, which produce large batches without patient-specific prescriptions, are federally regulated by FDA and may not compound finasteride unless it appears on the FDA's 503B bulks list. As of 2025, finasteride is not on that approved 503B bulks list, so large-batch compounding without prescriptions is not permitted [12].

Telehealth Prescribing of Finasteride in Florida

Florida permits telehealth prescribing of finasteride by licensed physicians and advanced practice registered nurses (APRNs). Florida Statute 456.47 governs telehealth practice and allows prescribing where an appropriate patient-provider relationship has been established via synchronous audio-video consultation [13]. Prescribing finasteride entirely by questionnaire without a live encounter is not compliant with Florida law for a new patient.

Several national telehealth platforms, including Hims, Keeps, and Roman, operate in Florida and can pair patients with Florida-licensed providers. After a video or synchronous consultation, a provider may transmit a finasteride prescription electronically to any Florida-licensed pharmacy, including mail-order pharmacies. Prescriptions for finasteride are not classified as controlled substances, which simplifies the telehealth workflow considerably.

HealthRX providers licensed in Florida follow a structured intake process that includes reviewing a patient's medical history, current medications, and PSA status in men over 40 before initiating finasteride. The FDA label for finasteride 5 mg (Proscar) includes a warning about its effect on PSA values, noting that finasteride decreases serum PSA by approximately 50%, which must be accounted for when monitoring for prostate cancer [14]. This consideration applies clinically even when 1 mg is prescribed.

A 2023 analysis published in JAMA Dermatology found that telehealth-initiated finasteride prescriptions were associated with adherence rates of 72% at 12 months, comparable to in-person prescribing cohorts [15]. Geographic access was the primary driver of telehealth utilization, with rural Florida counties showing the highest rates of telehealth-initiated AGA treatment.

Insurance Coverage for Finasteride in Florida

Most private insurance plans in Florida classify finasteride for AGA as a cosmetic treatment and exclude it from coverage. Coverage for the BPH indication (5 mg) is more common, with many commercial plans placing generic finasteride 5 mg on Tier 1 formularies with a $0 to $10 copay.

The Affordable Care Act (ACA) marketplace plans sold in Florida do not mandate finasteride coverage for hair loss. Employer-sponsored plans operate under ERISA, which means benefit design is largely at the employer's discretion [16]. Some self-insured employers include finasteride for AGA on their formularies as part of comprehensive men's health benefits, but this is not the norm.

Patients with UnitedHealthcare, Aetna, BCBS of Florida, or Humana should check their specific plan's Summary of Benefits and Coverage document. Generic finasteride 5 mg for BPH frequently appears at Tier 1 under these carriers in Florida. The 1 mg AGA formulation is rarely covered. If a provider prescribes 5 mg for AGA off-label, the insurance outcome depends on the plan's medical necessity criteria and whether they apply dose-based coverage logic.

FSA and HSA funds are usable for prescription finasteride regardless of insurance status, since it is a prescription drug [17]. Florida residents with high-deductible health plans who have not met their deductible will still pay cash-pay rates, making discount programs the more practical route.

Discount Programs and Savings Cards for Finasteride in Florida

GoodRx is the most widely used discount tool in Florida for finasteride. Presenting a GoodRx coupon at a participating pharmacy bypasses insurance and applies a negotiated rate. Prices shown on GoodRx for finasteride 1 mg 30 tablets in major Florida ZIP codes range from $6 to $14 depending on pharmacy.

Merck does not currently offer a widely available patient assistance program for Propecia (brand finasteride 1 mg) given that generic substitutes are so inexpensive. However, the Merck Patient Assistance Program covers other Merck products and may be a resource for uninsured patients in financial hardship situations [18]. Applications require income documentation and a prescriber attestation.

NeedyMeds and RxAssist maintain databases of state and manufacturer programs relevant to Florida residents [19]. The 340B Drug Pricing Program is another avenue: federally qualified health centers (FQHCs) in Florida that participate in 340B can dispense finasteride at substantially reduced prices to eligible low-income patients. Federally qualified health centers in Florida include more than 50 organizations operating over 600 service sites [20].

Mark Cuban's Cost Plus Drugs (CostPlusDrugs.com) lists finasteride 1 mg at $6 for 90 tablets (roughly $2 per month) plus a $5 shipping fee, available to Florida residents [21]. This is among the lowest publicly available prices nationally. Prescriptions can be sent directly to Cost Plus Drugs by a Florida-licensed provider.

The HealthRX Price Decision Framework for Florida patients weighing their finasteride access options works as follows. Start with generic cash-pay using a GoodRx or Cost Plus Drugs coupon if cost is the primary concern. If insurance covers BPH-indication 5 mg, ask your provider whether that dosing makes clinical sense for your case. If topical finasteride or a combination topical is clinically indicated, a licensed 503A compounding pharmacy is the legal route, with costs near $45 per month. Reserve telehealth platforms for geographic or schedule convenience, not cost savings, since telehealth visit fees may offset pharmacy savings.

Clinical Efficacy: What Florida Patients Are Paying For

Finasteride works by selectively inhibiting type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) in hair follicles and the prostate [22]. Oral finasteride 1 mg reduces serum DHT by approximately 60% to 70%, which slows follicle miniaturization in androgenetic alopecia.

The landmark Kaufman et al. 1998 trial (N=1,553 men, 2 years) found that 83% of finasteride-treated men maintained or increased their hair count versus 28% in the placebo group [23]. Hair count increased by a mean of 107 hairs per 1-inch circle in the finasteride group compared with a loss of 50 hairs in placebo-treated men. This trial established the evidence base that continues to support finasteride as first-line pharmacotherapy for AGA.

The FDA approved Proscar (finasteride 5 mg) in 1992 for BPH and Propecia (finasteride 1 mg) in 1997 for AGA in men [24]. The drug is not FDA-approved for use in women of childbearing potential, and the label carries a Pregnancy Category X designation due to the risk of feminization of male fetuses. Postmenopausal women with AGA may be considered for off-label use under specialist guidance, though evidence is more limited than in men [25].

Long-term data from the Prostate Cancer Prevention Trial (PCPT, N=18,882) showed that finasteride 5 mg daily reduced prostate cancer incidence by 24.8% over 7 years compared with placebo [26]. This trial also raised early concerns about high-grade prostate cancer, though subsequent analyses, including a 2013 NEJM follow-up, found no increase in overall prostate cancer mortality in the finasteride group [27].

Side Effects That Affect Patient Decision-Making in Florida

Sexual side effects are the most discussed concern with finasteride. The FDA label reports that 3.8% of men in clinical trials experienced decreased libido, 1.3% had ejaculation disorder, and 1.3% reported erectile dysfunction, compared with 2.1%, 0.7%, and 1.1% respectively in placebo groups [28]. These rates are low, but the concept of post-finasteride syndrome (PFS) has led some patients to seek the topical route to reduce systemic DHT suppression.

The FDA added a label update in 2012 requiring disclosure of persistent sexual, mood, and cognitive side effects reported after drug discontinuation [29]. The Post-Finasteride Foundation maintains a patient registry, and several case series have been published, though causality in individual cases remains debated in the literature [30].

Breast cancer in men is listed as a rare adverse event. Patients who notice breast lumps, pain, nipple discharge, or enlargement should contact their provider promptly. The incidence in clinical trials was less than 1 in 1,000 patients but is retained as a label warning given the potential severity [28].

For Florida patients weighing these risks, the American Academy of Dermatology (AAD) guidelines note that "finasteride is generally well tolerated in the majority of men" and recommend discussing side effects during shared decision-making before prescribing [31].

Practical Steps for Florida Patients Starting Finasteride in 2026

A Florida-licensed provider, either in person or via compliant telehealth, must write the prescription. There is no path to obtaining finasteride legally without one. The prescription can be sent to any Florida-licensed retail or mail-order pharmacy, or to a licensed 503A compounder if a custom formulation is requested.

Men over 40 should have a PSA level drawn before starting finasteride, as the drug suppresses PSA by approximately 50% within 6 months of initiation. Any PSA increase while on finasteride should be interpreted as potentially doubling the clinical significance, per FDA label guidance [14]. The American Urological Association (AUA) 2021 guideline on BPH management affirms this monitoring requirement [32].

Results take time. Most patients see meaningful hair retention at 6 months and maximum benefit by 12 to 24 months. Stopping the drug reverses DHT suppression within 14 days, and hair loss typically resumes to its natural trajectory within 9 to 12 months of discontinuation [23].

The lowest-cost compliant path for a new Florida patient in 2026: book a telehealth visit with a Florida-licensed provider (typically $25 to $75 for the visit), receive an electronic prescription, and fill it at Cost Plus Drugs or with a GoodRx coupon at a local pharmacy for approximately $6 to $12 per month.